@article{4466df27cd0e44e9a8d6dfbea08d8e8e,
title = "A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: A gynecologic oncology group trial",
keywords = "GOG, Irofulven, Platinum-sensitive ovarian cancer, Primary peritoneal cancer",
author = "Schilder, {Russell J.} and Blessing, {John A.} and Shahin, {Mark S.} and Miller, {David S.} and Tewari, {Krishnansu Sujata} and Muller, {Carolyn Y.} and Warshal, {David P.} and Scott McMeekin and Jacob Rotmensch",
year = "2010",
month = oct,
doi = "10.1111/IGC.0b013e3181e8df36",
language = "English (US)",
volume = "20",
pages = "1137--1141",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Wolters Kluwer Health",
number = "7",
}